StonvexLoading…
StonvexStonvexStonvexCore line items from SOPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $77.27M | $65.17M | $62.37M | $47.56M |
Operating Income | $-70.91M | $-66.57M | $-74.83M | $-87.82M |
Net Income | $-79.00M | $-62.49M | $-78.98M | $-87.45M |
EPS (Diluted) | $-1.17 | $-0.95 | $-1.22 | $-1.36 |
Total Assets | $163.03M | $155.31M | $206.16M | $243.84M |
Total Liabilities | $115.89M | $58.82M | $54.71M | $43.71M |
Cash & Equivalents | $70.29M | $80.23M | $123.25M | $161.31M |
Free Cash Flow OCF − CapEx | $-36.47M | $-44.76M | $-54.72M | $-74.19M |
Shares Outstanding | Not available | Not available | Not available | Not available |